We are experts in the research and production of small molecules for the pharmaceutical industry. We also have a 40-year legacy of research and development, the most promising of which forms our drug discovery pipeline.
Changing the face of disease through the accelerated advancement of our pipeline
Edmonton’s General Intermediates of Canada Inc. (GIC) announced today that they have received conditional funding from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) related to their discovery ...
Edmonton’s General Intermediates of Canada Inc. (GIC) announced today that they have successfully completed a research project related to a key starting API material for a global ...